Abstract
The development of ligands for the A(3) adenosine receptor (AR) has been directed mainly by traditional medicinal chemistry, but the influence of structure-based approaches is increasing. Rhodopsin-based homology modeling had been used for many years to obtain three-dimensional models of the A(3)AR, and different A(3)AR models have been published describing the hypothetical interactions with known A(3)AR ligands having different chemical scaffolds. The recently published structure of the human A(2A)AR provides a new template for GPCR modeling, however even use of the A(2A)AR as a template for modeling other AR subtypes is still imprecise. The models compared here are based on bovine rhodopsin, the human beta(2)-adrenergic receptor, and the A(2A)AR as templates. The sequence of the human A(3)AR contains only one cysteine residue (Cys166) in the second extracellular loop (EL2), which putatively forms a conserved disulfide bridge with the respective cysteine residues of TM3 (Cys83). Homology models of the A(3)AR have been helpful in providing structural hypotheses for the design of new ligands. Site-directed mutagenesis of the A(3)AR shows an important role in ligand recognition for specific residues in TM3, TM6 and TM7.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.